Ledger.Open graph →
SEC Form D · filed March 7, 2017

Thrive Bioscience, Inc

Offering
$10.0M
Sold
$7.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Wakefield, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Alan P. Blanchard · Wakefield, MAExec · DirectorMichael P. Finney · Wakefield, MADirectorThomas F. Farb · Wakefield, MAExec · DirectorBrock P. Reeve · Beverly, MADirectorGuy P. Broadbent · Beverly, MADirectorPaul Crowley · BOSTON, MADirectorChristy Ai · San Francisco, CADirectorFranklin D. Myers · Sneek, P7DirectorAngelique-Johanna I. Brandt · Sneek, P7Exec · DirectorBCCM Advisors, LLC · Minneapolis, MNExec · DirectorKenneth Ray · York, MEExec · DirectorPaul Turek · San Francisco, CAExec · DirectorFiona M. Darmon · Jerusalem, L3DirectorYoav M. Tzruya · Jerusalem, L3Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗